{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:54:58Z","timestamp":1787064898622,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.urolonc.2025.09.015","type":"journal-article","created":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T03:03:18Z","timestamp":1760842998000},"page":"71.e9-71.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of oncologic outcomes following robot-assisted radical prostatectomy in high- and very high-risk prostate cancer based on the 2025 National Comprehensive Cancer Network risk stratification"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1633-784X","authenticated-orcid":false,"given":"Yu","family":"Ozawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shady","family":"Saikali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio Covas","family":"Moschovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Gamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2025.09.015_bib0001","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/pros.24184","article-title":"Increasing rates of NCCN high and very high-risk prostate cancer versus number of prostate biopsy cores","volume":"81","author":"Wenzel","year":"2021","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1590\/s1677-5538.ibju.2023.0530","article-title":"Impacts on functional and oncological outcomes of robotic-assisted radical prostatectomy 10 years after the US Preventive Service Taskforce recommendations against PSA screening","volume":"50","author":"Moschovas","year":"2024","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0003","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4111\/icu.2017.58.6.423","article-title":"US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses","volume":"58","author":"Gejerman","year":"2017","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.2246","article-title":"Trends in incidence of metastatic prostate cancer in the US","volume":"5","author":"Desai","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/cncr.31833","article-title":"Outcomes of very high-risk prostate cancer after radical prostatectomy: validation study from 3 centers: VHR criteria identify aggressive PCa","volume":"125","author":"Sundi","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0006","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/pcan.2013.46","article-title":"Very-high-risk localized prostate cancer: definition and outcomes","volume":"17","author":"Sundi","year":"2014","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0007","unstructured":"NCCN guideline: National Comprehensive Cancer Network\u00ae. NCCN guidelines version 1. 2025: prostate cancer. NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae). Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf. Accessed January 20, 2025."},{"key":"10.1016\/j.urolonc.2025.09.015_bib0008","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00345-020-03163-6","article-title":"Robotic surgery in urology: the way forward","volume":"38","author":"Autorino","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0009","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1007\/s00345-021-03687-5","article-title":"Robot-assisted radical prostatectomy versus standard laparoscopic radical prostatectomy: an evidence-based analysis of comparative outcomes","volume":"39","author":"Carbonara","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0010","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2021.07.025","article-title":"Functional and oncological outcomes after open versus robot-assisted laparoscopic radical prostatectomy for localised prostate cancer: 8-year follow-up","volume":"80","author":"Lantz","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0011","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00345-017-2021-9","article-title":"Surgical method influences specimen margins and biochemical recurrence during radical prostatectomy for high-risk prostate cancer: a systematic review and meta-analysis","volume":"35","author":"Srougi","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0012","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.eururo.2012.11.049","article-title":"Comparisons of the perioperative, functional, and oncologic outcomes after robot-assisted versus pure extraperitoneal laparoscopic radical prostatectomy","volume":"65","author":"Ploussard","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0013","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.juro.2017.02.070","article-title":"Oncologic and functional outcomes after radical prostatectomy for high or very high risk prostate cancer: European validation of the current NCCN\u00ae guideline","volume":"198","author":"Pompe","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0014","first-page":"245","article-title":"Prostate cancer\u2014major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Buyyounouski","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0015","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.eururo.2020.05.041","article-title":"Modified apical dissection and lateral prostatic fascia preservation improves early postoperative functional recovery in robotic-assisted laparoscopic radical prostatectomy: results from a propensity score-matched analysis","volume":"78","author":"Covas Moschovas","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0016","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.eururo.2018.12.014","article-title":"Guidelines for reporting of statistics for clinical research in urology","volume":"75","author":"Assel","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0017","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.euf.2021.04.020","article-title":"Patient- and tumour-related prognostic factors for urinary incontinence after radical prostatectomy for nonmetastatic prostate cancer: a systematic review and meta-analysis","volume":"8","author":"Lardas","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0018","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.euo.2021.01.001","article-title":"Management of persistently elevated prostate-specific antigen after radical prostatectomy: a systematic review of the literature","volume":"4","author":"Ploussard","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0019","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1158\/1940-6207.CAPR-10-0229","article-title":"Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis","volume":"4","author":"Cao","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0020","doi-asserted-by":"crossref","first-page":"415.e7","DOI":"10.1016\/j.urolonc.2016.04.002","article-title":"Racial\/ethnic differences in the relative risk of receipt of specific treatment among men with prostate cancer","volume":"34","author":"Moses","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0021","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/JU.0000000000001895","article-title":"A predictive preoperative and postoperative nomogram for postoperative potency recovery after robot-assisted radical prostatectomy","volume":"206","author":"Bhat","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0022","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41585-021-00514-9","article-title":"Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer","volume":"18","author":"Devos","year":"2021","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0023","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.urology.2010.02.069","article-title":"Prediction of mortality after radical prostatectomy by Charlson comorbidity index","volume":"76","author":"Guzzo","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0024","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1245\/s10434-018-7035-z","article-title":"Neoadjuvant androgen deprivation therapy prior to radical prostatectomy: recent trends in utilization and association with postoperative surgical margin status","volume":"26","author":"McClintock","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0025","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.eururo.2011.02.026","article-title":"Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence","volume":"59","author":"Boorjian","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0026","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41585-021-00497-7","article-title":"Salvage therapy for prostate cancer after radical prostatectomy","volume":"18","author":"Zaorsky","year":"2021","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0027","first-page":"1","article-title":"Recent advances in the management of high-risk localized prostate cancer: local therapy, systemic therapy, and biomarkers to guide treatment decisions","volume":"40","author":"McKay","year":"2020","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0028","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1377\/hlthaff.2020.00284","volume":"39","author":"Buxbaum","year":"2020","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0029","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.euo.2023.11.021","article-title":"Assessing the impact of positive surgical margins on mortality in patients who underwent robotic radical prostatectomy: 20 years\u2019 report from the EAU Robotic Urology Section Scientific Working Group","volume":"7","author":"Pellegrino","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2025.09.015_bib0030","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(21)02437-5","article-title":"Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol","volume":"399","author":"Attard","year":"2022","journal-title":"Lancet"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925003916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925003916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T13:00:09Z","timestamp":1765285209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925003916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1078143925003916"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.09.015","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of oncologic outcomes following robot-assisted radical prostatectomy in high- and very high-risk prostate cancer based on the 2025 National Comprehensive Cancer Network risk stratification","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}